B.I.R.O. Report

EUBIROD source: 319761ea64b939fa1be95f0c7eb6e8c07691f006

Input Database: birobox_ce_central_db

Output Directory Report: /home/birox/shared/wd/_ce_/report-structure/run-20120218201402/2010

General Population

No.Subjects

Demographic characteristics

1.1 Basic demographics

1.1.1 Age (Classes)

Clinical characteristics

2.1 Diabetes status

2.1.1 Type of diabetes
2.1.2 Duration of diabetes (Classes)

2.2 Risk factors

2.2.1 Obesity

2.2.1.1 Weight (most recent measurement in 12 mts)
2.2.1.2 BMI

2.2.2 Lifestyle

2.2.2.1 Smoking status

2.2.3 Clinical measurements

2.2.3.1 Systolic BP (most recent measurement in 12 mts)
2.2.3.2 Diastolic BP (most recent measurement in 12 mts)
2.2.3.3 Total cholesterol
2.2.3.4 HDL-cholesterol
2.2.3.5 Creatinine
2.2.3.6 HbA1c

2.3 Diabetes complications

2.3.1 Retinopathy
2.3.2 End stage renal failure
2.3.3 Foot ulcer
2.3.4 Lower extremity amputation
2.3.5 Stroke
2.3.6 Myocardial infarction
2.3.7 Hypertension

Health system

3.1 Structure (provider level)

3.1.1 Type of provider
3.1.2 Average diabetes population per centre

3.2 Structural quality

3.2.1 Hospital beds per 100,000
3.2.2 Physicians employed per 100,000

3.3 Processes

3.3.1 Foot Exam

3.3.1.1 Foot Exam: Done

3.3.2 Eye Exam

3.3.2.1 Eye Exam: Done

3.3.3 Measurement done

3.3.3.1 BP (1+ measurements in 12 mts)
3.3.3.2 Lipids (1+ measurements in 12 mts)
3.3.3.3 Microalbuminuria (1+ measurements in 12 mts)
3.3.3.4 HbA1c (1+ measurements in 12 mts)

3.3.4 Treatment

3.3.4.1 Antihypertensive Medication (1+ in 12 mts)
3.3.4.2 Lipid Lowering Treatment (1+ in 12 mts)
3.3.4.3 Antiplatelet therapy (1+ in 12 mts)

3.3.4.4 Glucose lowering treatment

3.3.4.4.1 Glucose Lowering: Diet Only
3.3.4.4.2 Glucose Lowering: Tablets Only
3.3.4.4.3 Glucose Lowering: Insulin Only
3.3.4.4.4 Glucose Lowering: Insulin and Tablets
3.3.4.4.5 Glucose Lowering: Insulin Pump

3.3.5 Management

3.3.5.1 Self Monitoring
3.3.5.2 Number of visits on record

Population

4.1 Vital Statistics

4.1.1 Total population
4.1.2 Life expectancy
4.1.3 Mortality

Risk adjusted indicators

5.1 Epidemiology

5.1.1 Prevalence of diabetes mellitus per 1,000
5.1.2 Age at diagnosis by 10 year age bands

5.2 Process quality

5.3 Outcome quality - Intermediate outcomes

5.3.1 Percentage of adults w most recent HbA1c>9.0 pct
5.3.2 Percentage of adults w most recent HbA1c>7.5 pct
5.3.3 Percentage of adults w most recent BP<140/90 mmHg
5.3.4 Percentage of adults w most recent BMI>30
5.3.5 Percentage of adults w normal microalb. in 12 mts (among tested)
5.3.6 Rate of current smokers among adults
5.3.7 Rate of foot ulceration in adults

5.4 Outcome Quality - Terminal outcomes

5.4.1 Annual incidence of dialysis and/or transplant among adults
5.4.2 End stage renal failure in adults

Pediatric Section

6.1 Pediatric Demographics

6.1.1 Age (Classes)

6.2 Diabetes Status

6.2.1 Type of Diabetes
6.2.2 Duration of diabetes (Classes)

6.3 Risk factors

6.3.1 Height (most recent measurement in 12 mts)
6.3.2 BMI (most recent measurement in 12 mts)

6.4 Clinical measurements

6.4.1 HbA1c (most recent measurement in 12 mts)
Appendix